ACADIA Pharmaceuticals Inc (ACAD) Stock Price

25.605 ▲ +0.765 (+3.08%)
Open: 25.26 Vol: 2.41K Day's range: 25.04 - 25.775 Jul 27, 15:37 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ACAD Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 25.60▼ 25.64▼ 25.59▼ 25.11▲ 25.63▼
MA10 25.67▼ 25.55▼ 25.29▲ 25.33▲ 23.94▲
MA20 25.67▼ 25.23▲ 25.05▲ 25.55▼ 22.79▲
MA50 25.57▼ 25.03▲ 25.19▲ 23.23▲ 23.64▲
MA100 25.32▲ 25.23▲ 25.52▼ 22.55▲ 21.01▲
MA200 25.06▲ 25.54▼ 24.65▲ 23.52▲ 20.95▲
  5 mins 30 mins Hourly Daily Weekly
MACD -0.027▼ 0.040▲ 0.109▲ -0.212▼ 0.464▲
RSI 36.814▼ 59.165▲ 59.452▲ 58.896▲ 59.330▲
STOCH 27.900     85.499▲ 91.736▲ 27.746     74.564    
WILL %R -93.103▼ -25.116     -22.407▲ -44.118     -25.749    
CCI -241.111▼ 49.451     76.867     -14.735     78.267    
Latest Filters Detected On ACAD
MA $ACAD Price Crossed Above MA(26) Set Alert
MA $ACAD Price Crossed Above MA(13) Set Alert
MA $ACAD Price Crossed Above MA(7) Set Alert
ACADIA Pharmaceuticals Inc News
ACADIA (ACAD) Upgraded to Buy After Recent Pullback
Saturday, May 02, 2026 06:51 AM
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) ranks among the most profitable biotech stocks to buy now. On March 25, BofA Securities raised ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to Buy from Neutral, ...
Exclusive BAC Article: Acadia Pharmaceuticals; Remilfanserin ADP Data August - October 2026, Over $1 Billion Sales Full-Year 2025, And Catalysts
Thursday, February 26, 2026 11:57 AM
I believe that a good speculative biotech to go over for the "Exclusive BAC Subscribers Article" would be Acadia Pharmaceuticals (ACAD). The reason why I want to go over this company next is because ...
Acadia Pharmaceuticals Announces Phase 3 COMPASS PWS Trial of Intranasal Carbetocin (ACP-101) for Hyperphagia in Prader-Willi Syndrome Did Not Meet Primary Endpoint
Wednesday, September 24, 2025 04:00 AM
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced top-line results from the Phase 3 COMPASS PWS trial evaluating the efficacy and safety of intranasal carbetocin ...
ACAD historical stock data
date open high low close volume
27/07/26 25.24 25.775 25.04 25.505 768,606
24/07/26 25.10 25.10 24.57 24.84 982,562
23/07/26 24.232 25.00 24.232 24.83 1,272,012
22/07/26 25.59 25.62 24.91 24.96 1,136,136
21/07/26 25.20 25.57 25.07 25.43 1,284,489
20/07/26 26.07 26.16 25.03 25.09 1,486,528
17/07/26 25.37 25.835 25.20 25.60 1,139,988
16/07/26 26.00 26.23 25.47 25.63 2,114,874
15/07/26 25.38 26.08 25.1804 25.92 1,273,559
14/07/26 25.58 25.64 24.955 25.49 1,221,006
Quote Details
52wk Low:19.69
52wk High:28.35
Vol:2.41K
Avg Vol(3m):30.4M
1Y Chng:+0.22%
1M Chng:+20.93%
Add to Watch List
More Information
Index US Composite
Market Cap. 4.25B